HomeCompareSCRPF vs MRK

SCRPF vs MRK: Dividend Comparison 2026

SCRPF yields 3.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.4K in total portfolio value
10 years
SCRPF
SCRPF
● Live price
3.81%
Share price
$5.30
Annual div
$0.20
5Y div CAGR
-46.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.4K
Annual income
$0.70
Full SCRPF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SCRPF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCRPFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCRPF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCRPF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCRPF
Annual income on $10K today (after 15% tax)
$323.67/yr
After 10yr DRIP, annual income (after tax)
$0.60/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,327.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCRPF + MRK for your $10,000?

SCRPF: 50%MRK: 50%
100% MRK50/50100% SCRPF
Portfolio after 10yr
$38.6K
Annual income
$4,899.42/yr
Blended yield
12.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SCRPF
No analyst data
Altman Z
1.7
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCRPF buys
0
MRK buys
0
No recent congressional trades found for SCRPF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCRPFMRK
Forward yield3.81%2.76%
Annual dividend / share$0.20$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-46.9%32.7%
Portfolio after 10y$20.4K$56.8K
Annual income after 10y$0.70$9,798.13
Total dividends collected$436.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCRPF vs MRK ($10,000, DRIP)

YearSCRPF PortfolioSCRPF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,902$202.20$11,206$366.19$304.00MRK
2$11,775$109.40$12,650$502.35$875.00MRK
3$12,658$58.63$14,407$694.19$1.7KMRK
4$13,575$31.28$16,585$967.82$3.0KMRK
5$14,542$16.65$19,342$1,363.89$4.8KMRK
6$15,569$8.85$22,913$1,947.19$7.3KMRK
7$16,663$4.70$27,662$2,823.89$11.0KMRK
8$17,832$2.50$34,159$4,173.35$16.3KMRK
9$19,082$1.33$43,337$6,308.80$24.3KMRK
10$20,418$0.70$56,776$9,798.13$36.4KMRK

SCRPF vs MRK: Complete Analysis 2026

SCRPFStock

Sembcorp Industries Ltd, an investment holding company, engages in the renewables, integrated urban solutions, conventional energy, and other businesses in Singapore, rest of southeast Asia, the Middle East, China, India, the United Kingdom, and internationally. The Renewables segment provides electricity from solar and wind resources and energy storage solutions, as well as system services that support integration of renewables into grid; and trades in energy attribute certificates. This segment also includes the development and provision of installation, operation, and maintenance of solar, wind, and energy storage assets. The Integrated Urban Solutions segment develops large-scale integrated urban and integrated townships, such as industrial parks, business, commercial and residential spaces, and production and reclamation of water and industrial wastewater treatment, as well as solid waste management and waste-to-resource solutions. This segment also comprises carbon capture, utilization, and storage projects. The Conventional Energy segment sells energy molecules, including natural gas, steam, and electricity from various fossil fuels, such as natural gas and coal. This segment also sells water products from its integrated assets. The company also engages in the terminalling and storage of petroleum products and chemicals; solid waste management, public cleaning, and recycling services; and construction and engineering related activities. In addition, it offers water products; and reclamation of water and industrial wastewater treatment services. The company was formerly known as Minaret Limited and changed its name to Sembcorp Industries Ltd in July 1998. Sembcorp Industries Ltd was incorporated in 1998 and is headquartered in Singapore.

Full SCRPF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SCRPF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCRPF vs SCHDSCRPF vs JEPISCRPF vs OSCRPF vs KOSCRPF vs MAINSCRPF vs JNJSCRPF vs ABBVSCRPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.